Publication: Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4.
| dc.contributor.author | Borràs, Carla | |
| dc.contributor.author | Canyelles, Marina | |
| dc.contributor.author | Santos, David | |
| dc.contributor.author | Rotllan, Noemí | |
| dc.contributor.author | Núñez, Estefanía | |
| dc.contributor.author | Vázquez, Jesús | |
| dc.contributor.author | Maspoch, Daniel | |
| dc.contributor.author | Cano-Sarabia, Mary | |
| dc.contributor.author | Zhao, Qi | |
| dc.contributor.author | Carmona-Iragui, Maria | |
| dc.contributor.author | Sirisi, Sònia | |
| dc.contributor.author | Lleó, Alberto | |
| dc.contributor.author | Fortea, Juan | |
| dc.contributor.author | Alcolea, Daniel | |
| dc.contributor.author | Blanco-Vaca, Francisco | |
| dc.contributor.author | Escolà-Gil, Joan Carles | |
| dc.contributor.author | Tondo, Mireia | |
| dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
| dc.contributor.funder | Centro de Investigación Biomédica en Red - CIBERNED (Enfermedades Neurodegenerativas) | |
| dc.contributor.funder | Instituto de Salud Carlos III | |
| dc.contributor.funder | Agencia Estatal de Investigación (España) | |
| dc.contributor.funder | Comunidad de Madrid (España) | |
| dc.contributor.funder | Fundación La Caixa | |
| dc.date.accessioned | 2025-12-15T14:36:14Z | |
| dc.date.available | 2025-12-15T14:36:14Z | |
| dc.date.issued | 2025-08 | |
| dc.description.abstract | In the central nervous system, apolipoprotein (APO)E-containing lipoprotein particles mediate the transport of glial-derived cholesterol to neurons, which is essential for neuronal membrane remodeling and maintenance of the myelin sheath. We aimed to examine cholesterol transport via lipoprotein particles in cerebrospinal fluid (CSF) of Alzheimer's disease (AD) patients compared to control individuals. Additionally, we explored the ability of reconstituted HDL containing different APOE isoforms to regulate cholesterol transport. We evaluated the capacity of CSF lipoprotein particles to facilitate radiolabeled unesterified cholesterol efflux from A172 human glioblastoma astrocytes and to deliver cholesterol to SH-SY5Y human neuronal cells. The CSF lipoprotein proteome was analyzed by LC-MS/MS. Reconstituted HDL nanoparticles were prepared by combining phospholipids and cholesterol with human APOE3 or APOE4, followed by radiolabeling with unesterified cholesterol. Our results showed that cholesterol efflux from astrocytes to CSF were similar between AD patients and controls, both under baseline conditions and after activation of ABCA1 and ABCG1. However, CSF lipoprotein-mediated neuronal cholesterol uptake was significantly reduced in the AD group. LC-MS/MS analysis identified 239 proteins associated with CSF lipoproteins in both groups, with no major alterations in proteins linked to cholesterol metabolism. However, 27 proteins involved in noncholesterol-related processes were differentially expressed. Notably, synthetic reconstituted HDL particles containing APOE4 exhibited reduced capacity to deliver cholesterol to neurons compared to those with APOE3. These findings indicate that CSF lipoproteins from patients with AD demonstrate impaired cholesterol delivery to neurons. Our study highlights APOE4 as a critical contributor to abnormal neuronal cholesterol uptake in AD pathophysiology. | |
| dc.description.peerreviewed | Sí | |
| dc.description.tableofcontents | This work was partly funded by the Instituto de Salud Carlos III and FEDER "Una manera de hacer Europa" grants PI2100140 (to F. B.-V. and M. T.), PI2300232 (to M. C. and J. E-G.), PI18/0035 and PI22/00758 (to M. C.-I.), JR22/00003 (to M. C.), INT21/00073, PI20/01473, and PI23/01786 (to J. F.) and the Centro de Investigacion´ Biomedica ´ en Red sobre Enfermedades Neurodegenerativas Program 1, partly jointly funded by Fondo Europeo de Desarrollo Regional, Union´ Europea, Una Manera de Hacer Europa, and cofunded by the European Regional Development Fund/ European Social Fund (ERDF/ESF), “A way to make Europe”/“Investing in your future”. This work was also supported by the National Institutes of Health grants (R01 AG056850; R21 AG056974, R01 AG061566, R01 AG081394, and R61AG066543 to J. F. It was also supported by Fundacion´ Tatiana Perez ´ de Guzman´ el Bueno (IIBSPDOW-2020-151 to J. F.) and Horizon 2020–Research and Innovation Framework Programme from the European Union (H2020-SC1-BHC-2018-2020 to J. F.). IBERDEM, CIBERCV, and CIBERNED are Instituto de Salud Carlos III projects. C. B. was funded with a Formacion´ de Profesorado Universitario grant FPU20/07440 from Ministerio de Universidades. Q. Z. was supported by the State Scholarship Fund from the China Scholarship Council (Grant No. 202406170068). N. R. was funded by Agencia Estatal de Investigacion´ (AEI/10.13039/501100011033) within the Subprograma Ramon´ y Cajal (RYC-201722879). ICN2 is supported by the Severo Ochoa Centers of Excellence program, Grant CEX2021-001214-S, funded by MCIN/AEI/ 10.13039.501100011033. This study was supported by competitive grants PID2021-122348NB-I00 funded by MICIU/AEI/10.13039/501100011033 (to J. V.) and by “ERDF A way of making Europe”, PLEC2022-009298, PLEC2022-009235, and EQC2021-007053-P funded by MICIU/AEI/ 10.13039/501100011033 (to J. V.) and by “European Union NextGenerationEU/PRTR”, S2022/BMD-7333-CM (INMUNOVAR-CM) funded by Comunidad de Madrid (to J. V.) and LCF/PR/HR22/52420019 funded by “la Caixa” Foundation (to J. V.) | |
| dc.identifier.citation | J Lipid Res. 2025 Aug;66(8):100865. | |
| dc.identifier.journal | JOURNAL OF LIPID RESEARCH | |
| dc.identifier.pubmedID | 40701521 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/27027 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI2100140 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI2300232 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI18/0035 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI22/00758 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI20/01473 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI23/01786 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/FPU20/07440 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/AEI/10.13039/501100011033 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/RYC-201722879 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PID2021-122348NB-I00 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/MICIU/AEI/10.13039/501100011033 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PLEC2022-009298 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PLEC2022-009235 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/EQC2021-007053-P | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/S2022/BMD-7333-CM | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/LCF/PR/HR22/52420019 | |
| dc.relation.publisherversion | https://doi.org/10.1016/j.jlr.2025.100865 | |
| dc.repisalud.institucion | CNIC | |
| dc.repisalud.orgCNIC | CNIC::Grupos de investigación::Proteómica cardiovascular | |
| dc.rights.accessRights | open access | |
| dc.rights.license | Attribution 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | APOE | |
| dc.subject | Alzheimer's disease | |
| dc.subject | CSF lipoprotein | |
| dc.subject | cholesterol | |
| dc.title | Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4. | |
| dc.type | research article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Cerebrospinal fluid lipoprotein_J Lipid Res_2025.pdf
- Size:
- 5.9 MB
- Format:
- Adobe Portable Document Format


